Mifepristone
| Full Name | Mifepristone |
| Drug | Mifepristone |
| Manufacturer | Generic |
| Route of Administration | Oral |
| Site of Care | Home |
| Approved Indication | Control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery |
| Disease | Cushing’s Syndrome |
| Therapeutic Area | Endocrinology |
| Enrollment Form Link | Mifepristone Enrollment Form |
| Phone Number | (888) 204-7730 |
| Fax Number | (877) 218-6288 |
| Product Website | https://www.tevausa.com/products/mifepristonetablets |